Blood pressure decrease correlates with tau pathology and memory decline in hypertensive elderly
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
In hypertension, cerebral blood flow regulation limits are changed, and the threshold for blood pressure at which perfusion is safely maintained is higher. This shift may increase the brain's vulnerability to lower blood pressure in subjects with vascular disease. We investigated whether longitudinal reduction in mean arterial pressure (MAP) was related to changes in CSF biomarkers of Alzheimer's disease in a group of cognitively healthy elderly with and without hypertension (HTN). The relationships between MAP, memory decline and hippocampal atrophy were also examined. Seventy-seven subjects (age 63.4±9.4, range 44-86 years; education 16.9±2.1, range 10-22 years; 60% women) were assessed twice, 2±0.5 years apart. At both time points, all subjects underwent full medical and neuropsychological evaluations, lumbar punctures and MRI examinations. Twenty-five subjects had HTN. Hypertensive and normotensive subjects did not differ in their CSF biomarkers, hippocampal volumes or memory scores at baseline. In the entire study group, the increase in p-tau181 was associated with a decline in verbal episodic memory (ß=−.30, p=.01) and hippocampal volume reduction (ß=−.27, p=.02). However, longitudinal decrease in MAP was related to memory decline (β=0.50, p=.01) and an increase in p-tau181 (β=−0.50, p=.01) only in subjects with hypertension. Our findings suggest that the hypertensive group may be sensitive to blood pressure reductions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
The age-dependent relation of blood pressure to cognitive function and dementia
Qiu, C., Winblad, B., & Fratiglioni, L. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70141-1 · Cited by 1,138
Blennow, K., Wallin, A., Ågren, H., Spenger, C., Siegfried, J., & Vanmechelen, E. (1995) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815140 · Cited by 789
Self-citationAndreasen, N., Hesse, C., Davidsson, P., Minthon, L., Wallin, A., Winblad, B., Vanderstichele, H., Vanmechelen, E., & Blennow, K. (1999) · Archives of Neurology · doi:10.1001/archneur.56.6.673 · Cited by 660
Self-citationHypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression
Sun, X., He, G., Qing, H., Zhou, W., Dobie, F., Cai, F., Staufenbiel, M., Huang, L. E., & Song, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606298103 · Cited by 605 · cited 5×
“…neuropathologic studies showed no increase in amyloid or neurofibrillary pathology with more advanced vascular brain damage (Schneider, 2009), whereas other reports (Sparks et al., 1995) and animal data (Koike et al., 2010; Sun et al., 2006) suggest that vascular disease can intensify AD pathology.”
BackgroundInfluentialvan Beek, A. H., Claassen, J. A., Rikkert, M. G. O., & Jansen, R. W. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.13 · Cited by 485 · cited 1×
“This shift may increase the brain’s vulnerability to hypoperfusion at lower BP values (van Beek et al., 2008), suggesting that higher pressure is needed to maintain an adequate flow.”
BackgroundMcGuinness, B., Todd, S., Passmore, P., & Bullock, R. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004034.pub3 · Cited by 315 · cited 1×
“Although recent studies show positive effects of antihypertensive therapy on the reduction of stroke and heart attack, the cognitive benefits from treatment are less compelling (Birns and Kalra, 2009; McGuinness et al., 2009).”
BackgroundCorrelates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia
Zarow, C., Vinters, H. V., Ellis, W. G., Weiner, M. W., Mungas, D., White, L., & Chui, H. C. (2005) · Annals of Neurology · doi:10.1002/ana.20503 · Cited by 241 · cited 1×
“It is also particularly sensitive to hypoperfusion (Zarow et al., 2005; ZolaMorgan et al., 1992).”
BackgroundNeuropsychological Prediction of Decline to Dementia in Nondemented Elderly
Kluger, A., Ferris, S. H., Golomb, J., Mittelman, M. S., & Reisberg, B. (1999) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879901200402 · Cited by 227
Cognitive function and hypertension
Birns, J., & Kalra, L. (2009) · Journal of Human Hypertension · doi:10.1038/jhh.2008.80 · Cited by 157
Cited by
Defining the relationship between hypertension, cognitive decline, and dementia: a review
Walker, K. A., Power, M. C., & Gottesman, R. F. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0724-3 · Cited by 394
Traumatic Brain Injury and Alzheimer's Disease: The Cerebrovascular Link
Ramos-Cejudo, J., Wisniewski, T., Marmar, C., Zetterberg, H., Blennow, K., de Leon, M. J., & Fossati, S. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.01.021 · Cited by 385
Self-citationAssociation of midlife to late-life blood pressure patterns with incident dementia
Walker, K. A., Sharrett, A. R., Wu, A., Schneider, A. L. C., Albert, M., Lutsey, P. L., Bandeen-Roche, K., Coresh, J., Gross, A. L., Windham, B. G., et al. (2019) · JAMA · doi:10.1001/jama.2019.10575 · Cited by 376
“Annual telephone follow-up with Six-Item Screener (SIS) and/or the Ascertain Dementia 8-Item Informant Questionnaire (AD8) n = 3279 80 (5) Visit 6b No.”
MethodHypoxia and brain aging: Neurodegeneration or neuroprotection?
Burtscher, J., Mallet, R. T., Burtscher, M., & Millet, G. P. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101343 · Cited by 324
The biological pathways of Alzheimer disease: a review
Calabrò, M., Department of Biomedical and Dental Sciences and Morphofunctional Imaging, U. O. M., Rinaldi, C., Santoro, G., & Crisafulli, C. (2021) · AIMS Neuroscience · doi:10.3934/neuroscience.2021005 · Cited by 265
Metadata
- Authors
- Glodzik, L., Rusinek, H., Pirraglia, E., McHugh, P., Tsui, W., Williams, S., Cummings, M., Li, Y., Rich, K., Randall, C., Mosconi, L., Osorio, R., Murray, J., Zetterberg, H., Blennow, K., & de Leon, M.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 35
- Issue
- 1
- Pages
- 64-71
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2022655041
- Cited by
- 76
- References
- 12
- FWCI
- 3.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Blood pressure decrease correlates with tau pathology and memory decline in hypertensive elderly. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2013.06.011
- The paper
- Glodzik, L., Rusinek, H., Pirraglia, E., McHugh, P., Tsui, W., Williams, S., Cummings, M., Li, Y., Rich, K., Randall, C., Mosconi, L., Osorio, R., Murray, J., Zetterberg, H., Blennow, K., & de Leon, M. (2014). Blood pressure decrease correlates with tau pathology and memory decline in hypertensive elderly. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2013.06.011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.